Cancer premiums and latency effects: A risk tradeoff approach for valuing reductions in fatal cancer risks (Q928723)

From MaRDI portal
Revision as of 08:30, 10 December 2024 by Import241208061232 (talk | contribs) (Normalize DOI.)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
scientific article
Language Label Description Also known as
English
Cancer premiums and latency effects: A risk tradeoff approach for valuing reductions in fatal cancer risks
scientific article

    Statements

    Identifiers